Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Esophageal Cancer Market?

In recent times, the market size for esophageal cancer has experienced robust growth. Projected growth from 2024 to 2025 sees an escalation from $1.39 billion to $1.51 billion, reflecting a compound annual growth rate (CAGR) of 9.0%. Factors that have driven the growth during this historical period are an upsurge in cancer occurrences, advancements in healthcare facilities, increase in alcohol consumption, an augmented demand for preventive healthcare remedies, and a surge in the occurrence of esophageal adenocarcinoma.

A surge in growth is anticipated in the esophageal cancer market size in the upcoming years, with projections suggesting a rise to $2.16 billion by 2029 at a compound annual growth rate or CAGR of 9.3%. Factors contributing to this rise during the forecast period include notably the increasing number of esophageal cancer cases, an enhanced public awareness of healthcare, upgraded healthcare infrastructure, along with incidence of chronic smoking and alcohol consumption, and an uptick in esophageal adenocarcinoma cases. Additionally, expected trends during the forecast period encompass progressive treatment options due to technological advancements, amplified investments in R&D, a rise in the application of precision medicine, the advent of targeted therapies, higher involvement in clinical trials, and partnerships among educational institutions, pharmaceutical firms, and healthcare institutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp

What Core Drivers Are Expected To Influence The Esophageal Cancer Market?

The surge in esophageal cancer is poised to catalyze the expansion of the esophageal cancer market. Esophageal cancer, a sinister disease striking the esophagus, the pipe-like organ linking the throat and the stomach, witnesses an increment in its incidence, inevitably escalating the need for diagnostic methods including endoscopy, imaging tests, and biopsies for detecting and affirming the existence of the ailment. Take, for example, the American Cancer Society, a professional organization based in the US, reported 16,120 new esophageal cancer-related fatalities in 2023, a figure expected to marginally rise to 16,130 in 2024. Thus, the escalating esophageal cancer incidences are anticipated to fuel the esophageal cancer market’s growth.

Which Segmentation Categories Are Highlighted In The Esophageal Cancer Market Analysis?

The esophageal cancermarket covered in this report is segmented –

1) By Type: Esophageal Squamous-Cell Carcinoma; Esophageal Adenocarcinoma; Other Types

2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users

Subsegments:

1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma; Advanced Squamous-Cell Carcinoma

2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma; Advanced Adenocarcinoma

3) By Other Types: Neuroendocrine Tumors; Sarcomas; Mixed Cell Type Carcinomas

Which Notable Trends Are Transforming The Esophageal Cancer Market Outlook?

The trend of acquiring approval for new drugs is gaining traction in the esophageal cancer market. This is a strategy employed by many top industry players looking to solidify their standing and get ahead in the highly competitive esophageal cancer market. An illustrative example occurred in May 2022, when American pharmaceutical firm Bristol Myers Squibb secured approval from the U.S. Food and Drug Administration (FDA) for their two medical products: Opdivo (nivolumab), an injectable medicine, and Opdivo in combination with Yervoy (ipilimumab). These products primarily target patients suffering from advanced or metastatic esophageal squamous cell carcinoma (ESCC). This permission came on the heels of a completed Phase 3 clinical trial that demonstrated improved survival rates among patients who were administered these drugs.

Who Are The Dominant Players In The Esophageal Cancer Market Today?

Major companies operating in the esophageal cancer market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Esophageal Cancer Market?

North America was the largest region in the esophageal cancer market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12637&type=smp

Browse Through More Reports Similar to the Global Esophageal Cancer Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model